We are live on ! Find out more
BCPEMI

Bain Capital Public Equity Management II Portfolio holdings

AUM $62.1M
1-Year Est. Return 25.46%
This Fund
S&P 500
This Quarter Est. Return
+5.63%
1 Year Est. Return
+25.46%
3 Year Est. Return
+200.73%
5 Year Est. Return
+313.45%
10 Year Est. Return
–
AUM
$3B
AUM Growth
+$137M
Cap. Flow
+$39.5M
Cap. Flow %
1.32%
Top 10 Hldgs %
50.14%
Holding
64
New
10
Increased
12
Reduced
18
Closed
19

Top Buys

Rank Stock Value
1
AIG icon
American International
AIG
+$164M
2
SPLK
Splunk Inc
SPLK
+$115M
3
RJF icon
Raymond James Financial
RJF
+$84.2M
4
FIVE icon
Five Below
FIVE
+$64M
5
EWBC icon
East-West Bancorp
EWBC
+$53M

Top Sells

Rank Stock Value
1
FOUR icon
Shift4
FOUR
+$100M
2
FISV
Fiserv Inc
FISV
+$97.7M
3
CRM icon
Salesforce
CRM
+$37.1M
4
NOW icon
ServiceNow
NOW
+$35.8M
5
DNA icon
Ginkgo Bioworks
DNA
+$35.2M

Sector Composition

Rank Sector Weight
1 Financials 29.98%
2 Consumer Discretionary 28.76%
3 Technology 17.46%
4 Communication Services 8.3%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLBE icon
26
Global E Online
GLBE
$6.86B
$51M 1.7%
804,778
-271,806
-25% -$16.4M
OWL icon
27
Blue Owl Capital
OWL
$19.2B
$44.6M 1.49%
2,992,647
-959,681
-24% -$15.1M
CCC
28
CCC Intelligent Solutions
CCC
$4.05B
$24.9M 0.83%
+2,187,650
New +$25.5M
IMCR icon
29
Immunocore
IMCR
$1.74B
$24.4M 0.81%
711,951
+73,746
+12% +$2.67M
TDOC icon
30
PUT
Teladoc Health
TDOC
$1.24B
$23.7M 0.79%
+257,700
New +$30.8M
SNY icon
31
Sanofi
SNY
$104B
$20.6M 0.69%
411,568
-161,476
-28% -$7.99M
BCRX icon
32
BioCryst Pharmaceuticals
BCRX
$2.64B
$19.8M 0.66%
1,427,377
-45,094
-3% -$597K
UBER icon
33
Uber
UBER
$160B
$18.9M 0.63%
450,212
– –
RCUS icon
34
Arcus Biosciences
RCUS
$3.66B
$17.1M 0.57%
422,765
-32,098
-7% -$1.25M
CYTK icon
35
Cytokinetics
CYTK
$10.6B
$15.6M 0.52%
341,272
-310,341
-48% -$12M
ARKG icon
36
PUT
ARK Genomic Revolution ETF
ARKG
$1.79B
$13.2M 0.44%
+215,000
New +$14.9M
AFMD
37
DELISTED
Affimed
AFMD
$13.1M 0.44%
237,310
+122,509
+107% +$7.57M
HYPR icon
38
Hyperfine
HYPR
$102M
$11.4M 0.38%
+1,569,686
New +$12.4M
XBI icon
39
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$7.36M 0.25%
65,700
-126,800
-66% -$15.3M
MRNA icon
40
PUT
Moderna
MRNA
$24.2B
$6.53M 0.22%
+25,700
New +$7.51M
ANAC
41
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
$5.86M 0.2%
599,517
– –
CRIS icon
42
Curis
CRIS
$4.83M
$2.01M 0.07%
1,055
-39
-4% -$92.7K
ANAC.WS
43
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
$114K ﹤0.01%
149,878
– –
ASZ.WS
44
DELISTED
Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
ASZ.WS
$54K ﹤0.01%
55,568
– –
BAC icon
45
PUT
Bank of America
BAC
$448B
– –
-533,400
Closed -$22.6M
BCRX icon
46
CALL
BioCryst Pharmaceuticals
BCRX
$2.64B
– –
-200,000
Closed -$2.87M
CCK icon
47
CALL
Crown Holdings
CCK
$13.1B
– –
-142,500
Closed -$14.4M
DNA icon
48
Ginkgo Bioworks
DNA
$506M
– –
-75,975
Closed -$35.2M
FISV
49
CALL
Fiserv Inc
FISV
$28B
– –
-125,600
Closed -$13.6M
FISV
50
Fiserv Inc
FISV
$28B
– –
-900,446
Closed -$97.7M
1
2
3

Similar funds

RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
KWM
KW Wealth Management Sacramento, California $65.9M AUM
AC
AIFG Consultants Halfmoon, New York $58.2M AUM 20.27% 1-Year Est. Return
RWA
Redmont Wealth Advisors Chicago, Illinois $66M AUM 13.09% 1-Year Est. Return
VI
VanderPol Investments Caledonia, Michigan $57.5M AUM 14.56% 1-Year Est. Return
QEI
QSV Equity Investors Naperville, Illinois $67.6M AUM 0.29% 1-Year Est. Return
BBW
Blue Barn Wealth Orem, Utah $68.7M AUM 16.42% 1-Year Est. Return

Bain Capital Public Equity Management II's Q4 2021 Portfolio in Review

As of Q4 2021, Bain Capital Public Equity Management II held 64 positions worth $3B, up 4.8% from $2.86B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Bain Capital Public Equity Management II's Q4 2021 filing shows 10 new, 12 increased, 18 reduced and 19 closed positions. Its largest new stake was American International: 2,874,361 shares worth $163M. The largest sale was Shift4, an estimated $100M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bain Capital Public Equity Management II's largest Q4 2021 buy was American International: 2,874,361 shares worth $163M.
  • Bain Capital Public Equity Management II added most to East-West Bancorp in Q4 2021, an estimated $53M increase.
  • Bain Capital Public Equity Management II's biggest Q4 2021 reduction was Salesforce, cutting an estimated $37.1M.
  • Bain Capital Public Equity Management II fully exited Shift4 in Q4 2021, selling an estimated $100M.
  • Bain Capital Public Equity Management II's ten largest holdings make up 50% of its $3B portfolio in Q4 2021.
  • Bain Capital Public Equity Management II opened 10 new positions and closed 19 in Q4 2021.
  • Bain Capital Public Equity Management II's portfolio value rose 4.8% quarter-over-quarter to $3B.

Based on Bain Capital Public Equity Management II's 13F filing for Q4 2021, filed 14 Feb 2022.